Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-002019
Filing Date
2019-02-14
Accepted
2019-02-14 11:26:41
Documents
30
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 217868
2 ex31-1.htm EX-31.1 19098
3 ex32-1.htm EX-32.1 6036
  Complete submission text file 0001493152-19-002019.txt   952550

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE lwel-20181231.xml EX-101.INS 107045
5 XBRL SCHEMA FILE lwel-20181231.xsd EX-101.SCH 12543
6 XBRL CALCULATION FILE lwel-20181231_cal.xml EX-101.CAL 19855
7 XBRL DEFINITION FILE lwel-20181231_def.xml EX-101.DEF 29561
8 XBRL LABEL FILE lwel-20181231_lab.xml EX-101.LAB 88739
9 XBRL PRESENTATION FILE lwel-20181231_pre.xml EX-101.PRE 68854
Mailing Address 100 SOUTH SAUNDERS RD, SUITE 150 LAKE FOREST IL 60045
Business Address 100 SOUTH SAUNDERS RD, SUITE 150 LAKE FOREST IL 60045 (847) 574 6288
Luckwel Pharmaceuticals Inc. (Filer) CIK: 0001567098 (see all company filings)

EIN.: 461660653 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 333-187874 | Film No.: 19602864
SIC: 2834 Pharmaceutical Preparations